Developer docs
API playgroundTry for free, no card

Search company profiles

CUHK Innovation

Full company profile

uuid003ksod

Namestring
CUHK Innovation
Legal namestring
CUHK Innovation Limited
Company typeenum
Private
Founded yearint
2023
Descriptiontext

CUHK Innovation Limited is a Hong Kong-domiciled, privately held investment company wholly owned by The Chinese University of Hong Kong. It deploys capital into early-stage startups that are affiliated with the university, defined as companies less than seven years old in which CUHK community members hold at least 15% ownership, or which use CUHK-generated intellectual property. The company does not develop technology products of its own; its offering is capital allocation, investor syndication, and ecosystem development, including flagship events (the annual Innovation Summit), commercialization training through the Deep-Tech Lab, and structured challenges such as the DFI Sustainability Innovation Challenge.

The investment vehicle is anchored by an institutional co-investor network led by Alibaba Hong Kong Entrepreneurs Fund as flagship partner, with Beyond Ventures (海闊天空創投), CICC (中金國際), China Prosperity Capital (國宏嘉信資本), Fresco Capital, and Greater Bay Area Homeland Investments as core participants. Strategic R&D partnerships flow through the Hong Kong Centre for Logistics Robotics (HKCLR), which has assembled 24 industry partners across humanoid and quadruped robotics, including AGIBOT, Deep Robotics, Yushu Technology, Lenovo Capital and Incubator Group, and VinMotion. Portfolio exposure includes AI-enabled diagnostics (MicroSigX Biotech Diagnostic's MSX Metagenie, an FDA Breakthrough Device for autism diagnosis using gut-microbiome analysis), and the broader CUHK IP base of 1,800+ patents in non-invasive prenatal testing and circulating-DNA cancer detection.

Operationally, the company runs with a 1-10 person team out of the CUHK campus in Shatin, led by CEO Joyce Ng (formerly of Cyberport Macro Fund and OurCrowd) with Dr. Norman Chan (former HKMA Chief Executive) on the Board. It serves the Greater Bay Area region, sources deal flow exclusively through CUHK's research and alumni pipeline, and has begun generating institutional credibility signals, most notably the 2025 Deloitte Greater Bay Area Technology Fast Program Award and the parent university's climb to 18th globally in the QS World University Rankings 2027.

Short descriptiontext

CUHK Innovation Limited is a Hong Kong-based investment fund wholly owned by The Chinese University of Hong Kong, deploying capital into CUHK-affiliated startups and commercializing university research output via an institutional co-investor network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHong Kong, Hong Kong SAR China
HQ citystring
Hong Kong
HQ countrystring
Hong Kong SAR China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
university venture capital, startup investment fund, deep tech investing, spinout commercialization, innovation funding
Industry2 codes
1Financial Services / Fintech Growth Equity
CodeFSANACAEPrimaryYes
2Education / EdTech Growth Equity
CodeFSANACALPrimaryNo
NAICS code2 codes
  • Funds, Trusts, and Other Financial Vehicles525
  • Other Financial Investment Activities5239
SIC code1 code
  • Investment Advice6282
Product category
University Venture Capital
Social media profiles1 record
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Others, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CUHK Innovation Limited is the investment arm and wholly-owned subsidiary of The Chinese University of Hong Kong (CUHK). It operates a venture capital fund that provides equity investments to early-stage startups affiliated with the CUHK ecosystem, targeting companies younger than seven years in which the CUHK community holds at least 15% equity or that leverage CUHK-generated intellectual property. The fund focuses on deep-tech sectors including AI, robotics, biotech, fintech, and smart city technologies, and co-invests alongside institutional investors such as Alibaba Hong Kong Entrepreneurs Fund, CICC, and Greater Bay Area Homeland Investments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Several CUHK startups founded by staff, students, and alumni have potential to become unicorns
Product overview1 text field

CUHK Innovation Limited is an investment fund established by The Chinese University of Hong Kong to invest in innovative businesses related to CUHK's technological innovations or its community of startup companies. The company provides funding support, investment eligibility assessment, and startup ecosystem development services. It does not offer technology products or software services.

Product and service2 records
1CUHK Innovation Investment Fund
CategoryVenture Capital Investment
Description

Equity investment fund that provides capital to early-stage startups less than 7 years old affiliated with CUHK, where the CUHK community holds at least 15% equity or the company uses CUHK-generated intellectual property. Targets deep-tech sectors including AI, robotics, biotech, fintech, and smart cities.

2Institutional Co-Investment Network
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AGIBOT is a mainland China robotics company and one of the 24 industry partners of the Hong Kong Centre for Logistics Robotics (HKCLR) at CUHK, supporting the Embodied AI Lab for humanoid robotics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Deep Robotics is a mainland China robotics company partnering with HKCLR's Embodied AI Lab, contributing to the development of humanoid and quadruped robotics platforms.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Yushu Technology is a mainland China technology company and one of the 24 strategic industry partners supporting HKCLR's robotics research and commercialization efforts.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lenovo Capital and Incubator Group is a strategic partner of HKCLR, providing technology and investment support for the robotics ecosystem development.

5VinMotion
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

VinMotion is a Vietnam-based technology company and one of the 24 industry partners of HKCLR, contributing to the international collaboration in robotics development.

eweek.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MicroSigX Biotech Diagnostic Limited partnered with CUHK's Faculty of Medicine to launch MSX Metagenie, a breakthrough AI-powered test for early autism diagnosis using gut microbiome analysis. Technology received FDA Breakthrough Device Designation in 2024.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CUHK Innovation

University Venture Capitalcuhkinnovation.hk

CUHK Innovation Limited is a Hong Kong-based investment fund wholly owned by The Chinese University of Hong Kong, deploying capital into CUHK-affiliated startups and commercializing university research output via an institutional co-investor network.

What CUHK Innovation does

CUHK Innovation Limited is a Hong Kong-domiciled, privately held investment company wholly owned by The Chinese University of Hong Kong. It deploys capital into early-stage startups that are affiliated with the university, defined as companies less than seven years old in which CUHK community members hold at least 15% ownership, or which use CUHK-generated intellectual property. The company does not develop technology products of its own; its offering is capital allocation, investor syndication, and ecosystem development, including flagship events (the annual Innovation Summit), commercialization training through the Deep-Tech Lab, and structured challenges such as the DFI Sustainability Innovation Challenge.

The investment vehicle is anchored by an institutional co-investor network led by Alibaba Hong Kong Entrepreneurs Fund as flagship partner, with Beyond Ventures (海闊天空創投), CICC (中金國際), China Prosperity Capital (國宏嘉信資本), Fresco Capital, and Greater Bay Area Homeland Investments as core participants. Strategic R&D partnerships flow through the Hong Kong Centre for Logistics Robotics (HKCLR), which has assembled 24 industry partners across humanoid and quadruped robotics, including AGIBOT, Deep Robotics, Yushu Technology, Lenovo Capital and Incubator Group, and VinMotion. Portfolio exposure includes AI-enabled diagnostics (MicroSigX Biotech Diagnostic's MSX Metagenie, an FDA Breakthrough Device for autism diagnosis using gut-microbiome analysis), and the broader CUHK IP base of 1,800+ patents in non-invasive prenatal testing and circulating-DNA cancer detection.

Operationally, the company runs with a 1-10 person team out of the CUHK campus in Shatin, led by CEO Joyce Ng (formerly of Cyberport Macro Fund and OurCrowd) with Dr. Norman Chan (former HKMA Chief Executive) on the Board. It serves the Greater Bay Area region, sources deal flow exclusively through CUHK's research and alumni pipeline, and has begun generating institutional credibility signals, most notably the 2025 Deloitte Greater Bay Area Technology Fast Program Award and the parent university's climb to 18th globally in the QS World University Rankings 2027.

CUHK Innovation firmographics

Firmographics
Name
CUHK Innovation
Legal name
CUHK Innovation Limited
Website
https://cuhkinnovation.hk
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
CUHK Innovation Limited is a Hong Kong-based investment fund wholly owned by The Chinese University of Hong Kong, deploying capital into CUHK-affiliated startups and commercializing university research output via an institutional co-investor network.
Ownership category
akta.pro rank

CUHK Innovation industry classification

Industry
Product category
University Venture Capital
NAICS
Funds, Trusts, and Other Financial Vehicles (525), Other Financial Investment Activities (5239)
SIC
Investment Advice (6282)
akta.pro primary industry
Financial Services / Fintech Growth Equity (FSANACAE)
akta.pro secondary industry
Education / EdTech Growth Equity (FSANACAL)

Keywords

  • University venture capital
  • Startup investment fund
  • Deep tech investing
  • Spinout commercialization
  • Innovation funding

Where CUHK Innovation is headquartered

Location

Headquarters

HQ city
Hong Kong
HQ country
Hong Kong SAR China
HQ region
Asia

Offices1 record

Markets served

CUHK Innovation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Others, Marketing or Sales

Distribution channels1 record

Marketing channels5 records

CUHK Innovation product offering

Product offering

Core offering

CUHK Innovation Limited is the investment arm and wholly-owned subsidiary of The Chinese University of Hong Kong (CUHK). It operates a venture capital fund that provides equity investments to early-stage startups affiliated with the CUHK ecosystem, targeting companies younger than seven years in which the CUHK community holds at least 15% equity or that leverage CUHK-generated intellectual property. The fund focuses on deep-tech sectors including AI, robotics, biotech, fintech, and smart city technologies, and co-invests alongside institutional investors such as Alibaba Hong Kong Entrepreneurs Fund, CICC, and Greater Bay Area Homeland Investments.

Product overview

CUHK Innovation Limited is an investment fund established by The Chinese University of Hong Kong to invest in innovative businesses related to CUHK's technological innovations or its community of startup companies. The company provides funding support, investment eligibility assessment, and startup ecosystem development services. It does not offer technology products or software services.

Differentiator

Problem solved

Functional benefit

Products and services

  • CUHK Innovation Investment Fund Equity investment fund that provides capital to early-stage startups less than 7 years old affiliated with CUHK, where the CUHK community holds at least 15% equity or the company uses CUHK-generated intellectual property. Targets deep-tech sectors including AI, robotics, biotech, fintech, and smart cities.
  • Institutional Co-Investment Network

Quantifiable outcome

  • Several CUHK startups founded by staff, students, and alumni have potential to become unicorns

Companies that use CUHK Innovation

Customer profile

Segments2 records

Ideal customer profiles2 records

CUHK Innovation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CUHK Innovation partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and supporting.

  • AGIBOTcoreStrategic or Co-development PartnerAGIBOT is a mainland China robotics company and one of the 24 industry partners of the Hong Kong Centre for Logistics Robotics (HKCLR) at CUHK, supporting the Embodied AI Lab for humanoid robotics.
  • Deep RoboticscoreStrategic or Co-development PartnerDeep Robotics is a mainland China robotics company partnering with HKCLR's Embodied AI Lab, contributing to the development of humanoid and quadruped robotics platforms.
  • Yushu TechnologycoreStrategic or Co-development PartnerYushu Technology is a mainland China technology company and one of the 24 strategic industry partners supporting HKCLR's robotics research and commercialization efforts.
  • Lenovo Capital and Incubator GroupcoreStrategic or Co-development PartnerLenovo Capital and Incubator Group is a strategic partner of HKCLR, providing technology and investment support for the robotics ecosystem development.
  • VinMotionsupportingStrategic or Co-development PartnerVinMotion is a Vietnam-based technology company and one of the 24 industry partners of HKCLR, contributing to the international collaboration in robotics development.
  • MicroSigX Biotech Diagnostic LimitedcoreStrategic or Co-development PartnerMicroSigX Biotech Diagnostic Limited partnered with CUHK's Faculty of Medicine to launch MSX Metagenie, a breakthrough AI-powered test for early autism diagnosis using gut microbiome analysis. Technology received FDA Breakthrough Device Designation in 2024.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

CUHK Innovation competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

CUHK Innovation social profiles

Digital presence

CUHK Innovation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CUHK Innovation leadership team

Management profile

Number of profiles

Profiles2 records

CUHK Innovation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CUHK Innovation M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CUHK Innovation

What does CUHK Innovation do?

CUHK Innovation Limited is the investment arm and wholly-owned subsidiary of The Chinese University of Hong Kong (CUHK). It operates a venture capital fund that provides equity investments to early-stage startups affiliated with the CUHK ecosystem, targeting companies younger than seven years in which the CUHK community holds at least 15% equity or that leverage CUHK-generated intellectual property. The fund focuses on deep-tech sectors including AI, robotics, biotech, fintech, and smart city technologies, and co-invests alongside institutional investors such as Alibaba Hong Kong Entrepreneurs Fund, CICC, and Greater Bay Area Homeland Investments.

Is CUHK Innovation a public or private company?

CUHK Innovation is a private company. It is classified as corporate owned and is currently operating.

When was CUHK Innovation founded?

CUHK Innovation was founded in 2023. It employs 1 to 10 people.

Where is CUHK Innovation based?

CUHK Innovation is headquartered in Hong Kong, Hong Kong SAR China, in the Asia region.

Does CUHK Innovation have an API?

No public API is recorded for CUHK Innovation.

What industry is CUHK Innovation in?

CUHK Innovation's product category is University Venture Capital. Its primary akta.pro industry code is FSANACAE, Financial Services / Fintech Growth Equity, with a secondary code of FSANACAL, Education / EdTech Growth Equity. Its NAICS code is 525 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CuhkProfessor Steven Gallagher published a co-authored article in the Hong Kong LawyerProfessor Steven Gallagher published a co-authored article in the August 2026 issue of Hong Kong Lawyer with Joshua Chu and Melizza Anievas. The article, titled 'Quantum Billing – 2,500 Hours a Year, Fitting 36 Hours in a Day & When Law Firm Billing-Math Managed to Bend the Laws of Physics to Its Will,' focuses on law firm billing practices.Media BulletinsBioMed Technology Among Pioneering Recipients of Investment from CUHK Innovation Limited for Microbiome-based Healthcare SolutionsBioMed Technology Holdings Limited, a microbiome-based healthcare startup founded by CUHK professors and alumni, has received an investment from CUHK Innovation Limited. This marks the first investment made by CUHK Innovation Limited since its establishment, providing BioMed with support to accelerate research and development initiatives. The company currently operates in Hong Kong, Macau, Mainland China, and Thailand, leveraging a database of over 10,000 data points to offer personalized health solutions.Laotian TimesBioMed Technology Among Pioneering Recipients of Investment from CUHK Innovation Limited for Microbiome-based Healthcare SolutionsCUHK Innovation Limited announced its first-ever investment in BioMed Technology Holdings Limited, a microbiome-focused healthcare startup founded by CUHK professors and alumni. This funding supports BioMed's R&D efforts for personalized human and veterinary solutions, including recent partnerships with PetSpace and PSG Vivet to develop pet microbiome products launching in Q3 2024.